Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of David Robbins
Introduction
David Robbins is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of medical diagnostics, particularly in the area of colorectal cancer. His innovative work has the potential to improve patient outcomes through early detection and monitoring.
Latest Patents
Robbins holds a patent for a method of diagnosing and monitoring colorectal cancer. This patent outlines methods for screening for colorectal cancer by measuring levels of HC gp-39. Additionally, it provides methods for monitoring patients already diagnosed with colorectal cancer. The patent also includes kits designed for the detection of HC gp-39, which are useful in both screening and monitoring patients.
Career Highlights
David Robbins is associated with SmithKline Beecham P.L.C., where he has been able to apply his expertise in medical diagnostics. His work has been instrumental in advancing methods that can lead to earlier detection of colorectal cancer, thereby improving treatment options for patients.
Collaborations
Robbins has collaborated with notable colleagues, including Robert B. Kirkpatrick and Stephen D. Holmes. These collaborations have likely contributed to the development and refinement of his innovative methods.
Conclusion
David Robbins exemplifies the impact that dedicated inventors can have on healthcare through their innovative solutions. His work in colorectal cancer diagnostics is a testament to the importance of research and development in improving patient care.